Senior insider sale
Chief Financial Officer at ALPHA TAU MEDICAL LTD. — senior position signals high conviction
$402.9K
60K shares
What this filing means
LEVY RAPHI plans to sell 60K shares of ALPHA TAU MEDICAL LTD. valued at approximately $402.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2026ACC: 0001976408-26-000019
Officer· Chief Financial Officer
Since Mar 2026
60K
Shares to sell
$402.9K
Approx. market value
87.50K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
8/8/2021
87.50KTotal acquired87.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/8/2021 | Restricted Stock Units N/A | 87.50K | — |
| Total | 87.50K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
4.40K
Market value
$31.2K
1/13/2026
—Completed
Units to sell
10.60K
Market value
$74.3K
1/12/2026
—Completed
Units to sell
10K
Market value
$69.0K
1/9/2026
—Completed
Units to sell
20K
Market value
$122.1K
1/8/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
15K
Market value
$106.3K
1/13/2026
Total
Units
60K
Value
$402.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/13/2026 | 4.40K | $31.2K | — | Completed |
1/12/2026 | 10.60K | $74.3K | — | Completed |
1/9/2026 | 10K | $69.0K | — | Completed |
1/8/2026 | 20K | $122.1K | — | Completed |
| Planned — Approximate Date | ||||
1/13/2026 | 15K | $106.3K | Nasdaq | Planned |
| Total | 60K | $402.9K | ||